Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AVEO Pharmaceuticals Inc. (AVEO)

0.625   -0.004 (-0.62%) 02-22 16:00
Open: 0.635 Pre. Close: 0.6289
High: 0.64 Low: 0.6136
Volume: 3,627,394 Market Cap: 100M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.641 - 0.644 0.644 - 0.647
Low: 0.603 - 0.606 0.606 - 0.609
Close: 0.625 - 0.63 0.63 - 0.635

Technical analysis

as of: 2019-02-22 4:40:09 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.69     One year: 2.34
Support: Support1: 0.56    Support2: 0.47
Resistance: Resistance1: 1.45    Resistance2: 2.00
Pivot: 0.61
Moving Average: MA(5): 0.64     MA(20): 0.85
MA(100): 1.90     MA(250): 2.28
MACD: MACD(12,26): -0.28     Signal(9): -0.30
Stochastic oscillator: %K(14,3): 16.77     %D(3): 10.77
RSI: RSI(14): 26.44
52-week: High: 3.59  Low: 0.56  Change(%): -78.2
Average Vol(K): 3-Month: 320081  10-Days: 613138

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
AVEO has closed below upper band by 36.6%. Bollinger Bands are 89.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to AVEO's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 07 Feb 2019 17:19:55 Z
The Zacks Analyst Blog Highlights: Gilead, Vertex, Celgene, Alkermes and AVEO

Wed, 06 Feb 2019 14:12:50 Z
Biotech Stock Roundup: Celgene Tops in Q4, Gilead Disappoints, ALKS & AVEO Sink

Fri, 01 Feb 2019 21:38:00 Z
Week Ahead In Pharmaceuticals: 6 Stocks To Watch (EOLS, AVRO, SGMO...)

Fri, 01 Feb 2019 16:51:26 Z
AVEO Oncology Plunges on Delay in Filing Fotivda NDA With FDA

Fri, 01 Feb 2019 00:12:00 Z
AVEO Crashes, FDA Approves 1st Generic Of ADVAIR DISKUS, 'Tis Advantage TTNP

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 125.35
Shares Float (M) 123.00
% Held by Insiders
% Held by Institutions 50.30
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.360
EPS Est. Current Year -0.550
EPS Est. Next Year -0.420
EPS Est. Next Quarter -0.090
Forward EPS -0.450
Book Value (p.s.) 60.660
PEG Ratio
Profit Margin
Operating Margin -690.59
Return on Assets (ttm) -75.4
Return on Equity (ttm) 45.3
Qtrly Rev. Growth -46.5
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -22.16
Levered Free Cash Flow (M) -11.12

Stock Valuations

P/E -1.74
P/E Growth Ratio -0.01
P/BV 0.01
P/S 2611458304.00
P/CF -3.54

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.